Cipla stock faces an October 27 results test after margin pressure
Published on 10/07/2026 at 09:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCipla stock (ISIN INE059A01026) was trading at INR 1,327.50 on the NSE on October 7, 2026 at 12:56 p.m. IST, down 0.95 percent on the session. The next results date is October 27, when Cipla is scheduled to report figures for the quarter and half year ended September 30, 2026, according to NSE India.
October 27 brings the next test
The upcoming report follows a mixed Q1 FY27 picture. According to ScanX News, consolidated revenue reached INR 70.8 billion in the quarter ended June 30, 2026, up 3.5 percent from the comparable period. Net income was INR 7.89 billion, down 39.2 percent year over year.
The pressure was visible in profitability. ScanX News reported an EBITDA margin of 16.7 percent for Q1 FY27, below Cipla's full-year guidance range of 18.5 percent to 20 percent. That gap makes the October report important because revenue growth alone has not yet translated into comparable earnings growth.
Consensus still points above the quote
The 12-month consensus on Investing.com is Buy, based on 36 analysts. The average target is INR 1,509.08, with estimates ranging from INR 1,170 to INR 1,768; the average target lies 13.7 percent above the October 7 price.
The same consensus table lists 22 Buy ratings, 10 Holds and 4 Sells. The figures frame the central investor debate: Cipla's top line is expanding, but the Q1 net income decline and margin shortfall leave execution on launches and cost control as the next measurable checkpoints.
Regulatory risk adds a counterweight
A separate operational issue came from Maharashtra. Sahi Markets reported that the Maharashtra FDA cancelled the sale and distribution licences of Cipla's Pune carrying and forwarding facility effective October 1, 2026, citing packaging and storage irregularities. The report said the action did not concern product safety, quality or efficacy, but it adds a compliance and distribution factor ahead of the results.
Stock remains below its yearly high
Cipla was last at INR 1,327.50 on the NSE on October 7, 2026 at 12:56 p.m. IST. Its market capitalization was INR 1.1 trillion, trading volume was 221,011 shares, and the 52-week range stood at INR 1,165.70 to INR 1,673.00.
Cipla stock facts
- Company: Cipla Limited
- ISIN: INE059A01026
- Ticker: CIPLA
- Trading venue: NSE
- Price (as of October 7, 2026, 12:56 p.m. IST): INR 1,327.50
- Market capitalization: INR 1.1 trillion (as of October 7, 2026)
- 52-week range: INR 1,165.70-1,673.00 (as of October 7, 2026)
- Sector / Industry: Healthcare / Pharmaceuticals
Upcoming dates for Cipla stock
- October 27, 2026: Q2 FY27 and half-year financial results
